Scinovex
article Open AccessTop 1% cited

Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease

Alimentary Pharmacology & Therapeutics · 2014 · Vol. 40(10) · pp. 1209–1222
Larysa FedchukFabio NascimbeniR. PaisFrédéric CharlotteChantal HoussetVlad Ratziuthe LIDO Study Group

Abstract

All five steatosis biomarkers can diagnose steatosis and are correlated with insulin resistance. They are confounded by fibrosis and inflammation, and do not accurately quantify steatosis; this may limit their clinical utility. More research is needed to identify truly independent and quantitative markers of steatosis.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseCardiovascular Function and Risk FactorsNonalcoholic fatty liver diseaseSteatosisMedicineLiver steatosisFatty liverInternal medicineGastroenterologyDiseaseNonalcoholic steatohepatitis

MeSH terms

BiopsyBlood GlucoseFatty LiverFemaleHumansInflammationInsulin ResistanceLiverLiver CirrhosisMaleMiddle AgedTriglyceridesBiomarkersAdiposity

Funding

  • Directorate-General for Research and Innovation
Citations
504
FWCI
13.51
field-weighted impact
References
57
Percentile
99%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.